BLOOMBERG: Sun Pharma to Buy India’s Ranbaxy for $4B

  

Bloomberg’s John Dawson reports on India’s largest drug maker agreeing to purchase Ranbaxy in a $4B stock transaction. He speaks to Rishaad Salamat on Bloomberg Television’s “On The Move Asia.”